{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:49:07Z","timestamp":1778287747276,"version":"3.51.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/wnf.0b013e318237709a","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T09:18:36Z","timestamp":1321694316000},"page":"224-233","source":"Crossref","is-referenced-by-count":18,"title":["A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar Disorder"],"prefix":"10.1097","volume":"34","author":[{"given":"William V.","family":"Bobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tynya D.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Bossaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":". The long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1185\/030079903125002801","article-title":"A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder.","volume":"20","author":"Dean","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0033291707000347","article-title":". Suicide and other causes of mortality in bipolar disorder: a longitudinal study.","volume":"37","author":"Dutta","year":"2007","journal-title":"Psychol Med"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":". The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S1461145711000885","article-title":". Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.","volume":"14","author":"Vieta","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1176\/ajp.155.1.30","article-title":". Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.","volume":"155","author":"Maj","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4088\/JCP.v63n0502","article-title":"Nonadherence with mood stabilizers: prevalence and predictors.","volume":"63","author":"Scott","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1176\/appi.ajp.159.11.1927","article-title":"Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.","volume":"159","author":"Scott","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-0447.2002.1r084.x","article-title":"Treatment non-adherence in affective disorders.","volume":"105","author":"Lingam","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.153.8.993","article-title":"Lithium use and discontinuation in a health maintenance organization.","volume":"153","author":"Johnson","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ps.52.6.805","article-title":"Using drug claims data to assess the relationship of medication adherence with hospitalization and costs.","volume":"52","author":"Svarstad","year":"2001","journal-title":"Psychiatr Serv"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0447.1981.tb00778.x","article-title":". Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.","volume":"64","author":"Ahlfors","year":"1981","journal-title":"Acta Psychiatr Scand"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1192\/bjp.148.6.723","article-title":". Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients.","volume":"148","author":"Esparon","year":"1986","journal-title":"Br J Psychiatry"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004850-199300820-00007","article-title":"Depot antipsychotics in bipolar affective disorder.","volume":"8","author":"White","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v67n0116","article-title":". Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.","volume":"67","author":"Cavazzoni","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":". A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord"},{"key":"R21-6-20210203","first-page":"56","article-title":"A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.","volume":"50-","author":"Yatham","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":". The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.","volume":"44","author":"Keller","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":". The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R28-6-20210203","first-page":"321","article-title":". Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005053-198506000-00005","article-title":". Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale.","volume":"173","author":"Lane","year":"1985","journal-title":"J Nerv Ment Dis"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"suppl 2","key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1399-5618.2009.00713.x","article-title":"Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium.","volume":"11","author":"Muzina","year":"2009","journal-title":"Bipolar Disord"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":". Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).","volume":"161","author":"Simon","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v64n0316","article-title":"Van den BD, Bellivier F, et al.. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.","volume":"64","author":"Henry","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-0327(93)90118-4","article-title":". Anxious and non-anxious bipolar disorder.","volume":"29","author":"Young","year":"1993","journal-title":"J Affect Disord"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":". Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1176\/appi.ajp.2009.09020218","article-title":". Anxiety and outcome in bipolar disorder.","volume":"166","author":"Coryell","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/070674370705200309","article-title":". Anxiety comorbidity and quality of life in bipolar disorder patients.","volume":"52","author":"Kauer-SantAnna","year":"2007","journal-title":"Can J Psychiatry"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-5618.2000.20308.x","article-title":"Impact of substance abuse on the course and treatment of bipolar disorder.","volume":"2","author":"Salloum","year":"2000","journal-title":"Bipolar Disord"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-5618.2006.00369.x","article-title":". Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.","volume":"8","author":"Marangell","year":"2006","journal-title":"Bipolar Disord"},{"key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.comppsych.2008.06.008","article-title":". Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.","volume":"50","author":"Sajatovic","year":"2009","journal-title":"Compr Psychiatry"},{"key":"R42-6-20210203","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.09m05214yel","article-title":". Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.","volume":"72","author":"Brooks","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopsych.2004.09.022","article-title":". Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.","volume":"56","author":"Calabrese","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1989.01810050015004","article-title":"Response to maintenance therapy in bipolar illness. Effect of index episode.","volume":"46","author":"Shapiro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1461145709990344","article-title":". Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.","volume":"13","author":"Cruz","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4088\/JCP.v67n1216","article-title":". Attitudes of psychiatrists toward antipsychotic depot medication.","volume":"67","author":"Heres","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R48-6-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psychres.2008.11.003","article-title":"Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.","volume":"175","author":"Jaeger","year":"2010","journal-title":"Psychiatry Res"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0033291702006797","article-title":"Psychiatrists attitudes to maintenance medication for patients with schizophrenia.","volume":"33","author":"Patel","year":"2003","journal-title":"Psychol Med"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201111000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:52:36Z","timestamp":1618278756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201111000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318237709a","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}